Skip to Content

TEVA 3145 (Cephalexin Monohydrate 250 mg)

Pill with imprint TEVA 3145 is Gray / Orange, Capsule-shape and has been identified as Cephalexin Monohydrate 250 mg. It is supplied by Teva Pharmaceuticals USA.

Cephalexin is used in the treatment of bacterial infection; skin or soft tissue infection; bladder infection; upper respiratory tract infection; bacterial endocarditis prevention (and more), and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Cephalexin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 3145

Cephalexin monohydrate 250 mg TEVA 3145
Cephalexin monohydrate 250 mg TEVA 3145
Cephalexin monohydrate 250 mg TEVA 3145

Cephalexin Monohydrate

Imprint:
TEVA 3145
Strength:
250 mg
Color:
Gray / Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
First generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide